Novel multifunctional biocompatible gelatin-oleic acid conjugate: Self-assembled nanoparticles for drug delivery

Journal of Biomedical Nanotechnology

Volumn 9, Issue 8, 2013, Pages 1416-1431

  Tran, Phuong Ha Lien ^a   Tran, Thao Truong Dinh ^a   Vo, Toi Van ^a   Vo, Chau Le Ngoc ^b   Lee, Beom Jin ^b  

^a INTERNATIONAL UNIVERSITY   (Viet Nam)

^b Ajou University   (South Korea)

Author keywords

Folic acid (FA); Gelatin OA conjugate (GOC); Paclitaxel; Protein conjugation; Self assembled nanoparticles; Targeted drug delivery

Indexed keywords

FOLIC ACIDS; GELATIN-OA CONJUGATE (GOC); PACLITAXEL; PROTEIN CONJUGATIONS; SELF ASSEMBLED NANOPARTICLES; TARGETED DRUG DELIVERY;

BIOCOMPATIBILITY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; NANOPARTICLES; OLEIC ACID; ORGANIC ACIDS; SOLUBILITY; X RAY DIFFRACTION;

CONTROLLED DRUG DELIVERY;

FOLIC ACID; GELATIN; NANOPARTICLE; OLEIC ACID; PACLITAXEL;

ARTICLE; BIOCOMPATIBILITY; CANCER CELL; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG TARGETING; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; LIGHT SCATTERING; PH; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; UTERINE CERVIX CANCER; X RAY POWDER DIFFRACTION; ZETA POTENTIAL;

ANTINEOPLASTIC AGENTS; BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; GELATIN; HELA CELLS; HUMANS; MATERIALS TESTING; NANOCONJUGATES; NEOPLASMS; OLEIC ACID;

EID: 84880870227     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1621     Document Type: Article

References (47)

1. P. A. Maury, D. N. Reinhoudt, and J. Huskens, Assembly of nanoparticles on patterned surfaces by noncovalent interactions, Current Opinion in Colloid and amp. Interface Science 13, 74 (2008).
2. A. Dessey, A. M. Piras, M. Alderighi, S. S. Sandreschi, and F. Chiellini, Doxorubicin loaded polyurethanes nanoparticles. Nano Biomed. Eng. 4, 83 (2012).
3. E. Anton, S. Kambalapally, T. Wilson, and N. Robert, Dextrancontaining nanocarriers significantly promote greater anchorage dependent cell growth and density compared to microcarriers. Nano Biomed. Eng. 4, 29 (2012).
4. S. Hua, C. Xiufeng, R. Jing, P. Xia, W. Juan, W. Can, and B. Chenchen, Application of rotatable central composite design in the preparation and optimization of poly(lactic-co-glycolic acid) nanoparticles for controlled delivery of HSA. Nano Biomed. Eng. 3, (2012).
5. H. Song, R. He, K. Wang, J. Ruan, C. Bao, N. Li, J. Ji, and D. Cui, Anti-HIF-1. antibody-conjugated pluronic triblock copolymers encapsulated with Paclitaxel for tumor targeting therapy. Biomaterials 31, 2302 (2010).
6. K. Kataoka, A. Harada, and Y. Nagasaki, Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv. Drug Delivery. Rev. 47, 113 (2001).
7. K. Akiyoshi and J. Sunamoto, Supramolecular assembly of hydrophobized polysaccharides. Supramolecular Science 3, 157 (1996).
8. J.-H. Kim, Y.-S. Kim, S. Kim, J.H. Park, K. Kim, K. Choi, H. Chung, S. Y. Jeong, R.-W. Park, I.-S. Kim, and I. C. Kwon, Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. J. Control Release 111, 228 (2006).
9. F.-P. Gao, H.-Z. Zhang, L.-R. Liu, Y.-S. Wang, Q. Jiang, X.-D. Yang, and Q.-Q. Zhang, Preparation and physicochemical characteristics of self-assembled nanoparticles of deoxycholic acid modified-carboxymethyl curdlan conjugates. Carbohydr. Polym. 71, 606 (2008).
10. L. Silvio, R. G. Courteney-Harris, and S. Downes, The use of gelatin as a vehicle for drug and peptide delivery. J. Mater. Sci.: Mater. Med. 5, 819 (1994).
11. Y. L. Su, Z. Y. Fu, J. Y. Zhang, W. M. Wang, H. Wang, Y. C. Wang, and Q. J. Zhang, Microencapsulation of radix salvia miltiorrhiza nanoparticles by spray-drying. Powder Technol. 184, 114 (2008).
12. T. Hosokawa, M. Yamauchi, Y. Yamamoto, K. Iwata, Y. Kato, and E. Hayakawa, Formulation development of a filter-sterilizable lipid emulsion for lipophilic KW-3902, a newly synthesized adenosine A1-receptor antagonist. Chem. Pharm. Bull. 50, 87 (2002).
13. A. Ledo-Suárez, L. Rodríguez-Sánchez, M. C. Blanco, and M. A. López-Quintela, Electrochemical synthesis and stabilization of cobalt nanoparticles, Physica Status Solidi. a. 203, 1234 (2006).
14. G. Maxwell, Synthetic Nitrogen Products: A Practical Guide to the Products and Processes, Springer, New York (2004).
15. A. K. Singla, A. Garg, and D. Aggarwal, Paclitaxel and its formulations. Int. J. Pharm. 235, 179 (2002).
16. National Code of Practice for the Preparation of Material Safety Data Sheets, 2nd ed., [NOHSC:2011(2003)] Copyright ©Kilford & Kilford Pty Ltd, October (2004).
17. K. Alfred, G. Carola, and B. Simone, Molecular interactions in conjugates of dicarboxylic acids and amino acids. J. Mol. Struct. 661-662, 239 (2003).
18. Y.-Q. Ye, F.-L. Yang, F.-Q. Hu, Y.-Z. Du, H. Yuan, and H.-Y. Yu, Core-modified chitosan-based polymeric micelles for controlled release of doxorubicin. Int. J. Pharm. 352, 294 (2008).
19. G. A. Digenis, T. B. Gold, and V. P. Shah, Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. J. Pharm. Sci. 83, 915 (1994).
20. C. Weber, C. Coester, J. Kreuter, and K. Langer, Desolvation process and surface characterisation of protein nanoparticles. Int. J. Pharm. 194, 91 (2000).
21. Y. B. Patil, U. S. Toti, A. Khdair, L. Ma, and J. Panyam, Singlestep surface functionalization of polymeric nanoparticles for targeted drug delivery. Biomaterials 30, 859 (2009).
22. V. Landry, B. Riedl, and P. Blanchet, Alumina and zirconia acrylate nanocomposites coatings for wood flooring: Photocalorimetric characterization. Prog. Org. Coat. 61, 76 (2008).
23. L. Friedman and K. Klemm, Diffusion velocity and molecular weight, II, The effect of pH upon particle size in gelatin solutions. J. Am. Chem. Soc. 61, 1747 (1939).
24. M. Jahanshahi and Z. Babaei, Protein nanoparticle: A unique system as drug delivery vehicles. Afr. J. Biotechnol. 7, 4926 (2008).
25. K. H. Min, J.-H. Kim, S. M. Bae, H. Shin, M. S. Kim, S. Park, H. Lee, R.-W. Park, I.-S. Kim, K. Kim, I. C. Kwon, S. Y. Jeong, and D. S. Lee, Tumoral acidic pH-responsive MPEG-poly(β-amino ester) polymeric micelles for cancer targeting therapy. J. Control Release 144, 259 (2010).
26. K. Murakami, S. Y. Chan, and A. Routtenberg, Protein kinase C activation by cis-fatty acid in the absence of Ca2+ and phospholipids. J. Biol. Chem. 261, 15424 (1986).
27. K. Y. Lee, I. C. Kwon, Y. H. Kim, W. H. Jo, and S. Y. Jeong, Preparation of chitosan self-aggregates as a gene delivery system. J. Control Release 51, 213 (1998).
28. K. Na, D. H. Lee, D. J. Hwang, H. S. Park, K. H. Lee, and Y. H. Bae, pH-Sensitivity and pH-dependent structural change in polymeric nanoparticles of poly(vinyl sulfadimethoxine)-deoxycholic acid conjugate. Eur. Polym. J. 42, 2581 (2006).
29. W. Franklin, M. Waintrub, D. Edwards, K. Christensen, P. Prendegrast, J. Woods, P. Bunn, and J. Kolhouse, New anti-lung cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma. Int. J. Cancer Suppl. 8, 89 (1994).
30. S. Weitman, R. Lark, L. Coney, D. Fort, V. Frasca, V. J. Zurawski, and B. Kamen, Distribution of the folate receptor GP38 in normal and malignat cell lines and tissues. Cancer Res. 52, 3396 (1992).
31. Y.-Y. Yang, Y. Wang, R. Powell, and P. Chan, Polymeric core-shell nanoparticles for therapeutics. Clin. Exp. Pharmacol. Physiol. 33, 557 (2006).
32. D. D. Lasic, F. J. Martin, A. Gabizon, S. K. Huang, and D. Papahadjopoulos, Sterically stabilized liposomes: A hypothesis on the molecular origin of the extended circulation times. Biochimica et Biophysica Acta. BBA.-Biomembranes 1070, 187 (1991).
33. V. Martin, Overview of paclitaxel (Taxol). Semin. Oncol. Nurs. 9, 2 (1993).
34. A. K. Bajpai and J. Choubey, In vitro release dynamics of an anticancer drug from swellable gelatin nanoparticles. J. Appl. Polym. Sci. 101, 2320 (2006).
35. Y. Jeong, Y. Shim, K. Song, Y. Park, H. Ryu, and J. Nah, Testosterone-encapsulated surfactant-free nanoparticles of poly(DLlactide-co- glycolide): preparation and release behavior. Bull. Korean Chem. Soc. 23, 1579 (2002).
36. F.-Y. Cheng, S. P.-H. Wang, C.-H. Su, T.-L. Tsai, P.-C. Wu, D.-B. Shieh, J.-H. Chen, P. C.-H. Hsieh, and C.-S. Yeh, Stabilizer-free poly(lactide-co- glycolide) nanoparticles for multimodal biomedical probes. Biomaterials 29, 2104 (2008).
37. Y. Zhang and R.-X. Zhuo, Synthesis and in vitro drug release behavior of amphiphilic triblock copolymer nanoparticles based on poly(ethylene glycol) and polycaprolactone. Biomaterials 26, 6736 (2005).
38. Y.-I. Jeong, J.-B. Cheon, S.-H. Kim, J.-W. Nah, Y.-M. Lee, Y.-K. Sung, T. Akaike, and C.-S. Cho, Clonazepam release from core-shell type nanoparticles in vitro. J. Control Release 51, 169 (1998).
39. J. You, X. Li, F. D. Cui, Y.-Z. Du, H. Yuan, and F. Q. Hu, Folateconjugated polymer micelles for active targeting to cancer cells: Preparation, in vitro evaluation of targeting ability and cytotoxicity. Nanotechnology 19, 1 (2008).
40. F. Danhier, N. Lecouturier, B. Vroman, C. Jérôme, J. Marchand-Brynaert, O. Feron, and V. Préat, Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation. J. Control Release 133, 11 (2009).
41. S. Prabha, W.-Z. Zhou, J. Panyam, and V. Labhasetwar, Sizedependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int. J. Pharm. 244, 105 (2002).
42. S. K. Sahoo, J. Panyam, S. Prabha, and V. Labhasetwar, Residual polyvinyl alcohol associated with poly(d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Control Release 82, 105 (2002).
43. E. Raymond, A. Hanauske, S. Faivre, E. Izbicka, G. Clark, E. Rowinsky, and D. Von Hoff, Effects of prolonged versus short-term exposure paclitaxel (taxol) on human tumor colony-forming units. Anticancer Drugs 8, 379 (1997).
44. J. Liebmann, J. A. Cook, C. Lipschultz, D. Teague, J. Fisher, and J. B. Mitchell, The influence of Cremophor EL on the cell cycle effects of paclitaxel (taxol) in human tumor cell lines. Cancer Chemother. Pharmacol. 33, 331 (1994).
45. F. Danhier, N. Magotteaux, B. Ucakar, N. Lecouturier, M. Brewster, and V. Préat, Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for Paclitaxel. Eur. J. Pharm. Biopharm. 73, 230 (2009).
46. U. Westedt, M. Kalinowski, M. Wittmar, T. Merdan, F. Unger, J. Fuchs, S. Schäller, U. Bakowsky, and T. Kissel, Poly(vinyl alcohol)-graft- poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment. J. Control Release 119, 41 (2007).
47. M. Breunig, S. Bauer, and A. Goepferich, Polymers and nanoparticles: Intelligent tools for intracellular targeting? Eur. J. Pharm. Biopharm. 68, 112 (2008).